MyTrialMyTrial
LearnExplorePricingSolutions
858-544-3636
About MyTrial
AM

Founder

Andrew Michael, MD

Founder & CEO, MyTrial

San Diego, California

The reason MyTrial exists is that the eligibility-to-enrollment pipeline — where 80% of trials fail — sits at the intersection of three skill sets that almost never appear in one person: medical training to read the protocol, ten years on the road as a CRA to know how the work actually flows, and modern AI engineering depth to ship what those two together demand. I have all three. So the right move is to build it.

Background.

  • Medical

    • MD — clinical training in oncology and primary care
    • Active California medical license
    • Continuing medical education in informatics and clinical research methodology
  • Clinical research

    • 10 years as a clinical research associate
    • 200+ site monitoring visits across oncology, cardiology, and neurology trials
    • ICH-GCP and 21 CFR Part 11 working knowledge from the inside
  • Technical

    • Production systems with Next.js 16, AI SDK 6, Postgres, pgvector
    • Eligibility-parsing pipeline with concept normalization across SNOMED, RxNorm, LOINC, MeSH
    • Multi-agent architectures with human-in-the-loop primitives

The founding insight.

“Most clinical research software is built by software people who learned the domain second-hand. The friction lives in the gap between what the protocol says and what the workflow actually looks like at 9:30 on a Tuesday morning, with a coordinator juggling four trials and a patient on the phone. You can't design for that gap if you haven't lived in it.”

What we're building is the layer that sits between protocol and workflow — eligibility parsing, site responsiveness, AI-pre-screened candidates, persistent chat. The patient gets clarity. The site gets ten minutes back per screening. The sponsor gets the enrollment timeline they planned.

None of that exists today. So we are building it.

Selected writing.

  • On the eligibility-parsing problem in modern oncology trials

    Working paper · 2026

  • Why AI-native is non-negotiable for clinical research infrastructure

    FreeGCP.com · 2026

  • What ten years on the road as a CRA taught me about why trials fail

    FreeGCP.com · 2025

Get in touch.

For partnership, advisor, or co-founder conversations, email andrew@mytrial.com. For everything else, the waitlist is the right way in.

Join the waitlistBack to About
MyTrialMyTrial

The AI operating system for clinical research — built for patients, sites, sponsors, and investigators.

Find a trial

  • Browse hub
  • All trials
  • Conditions
  • Locations
  • Sponsors
  • Sites
  • Search

For sites + sponsors

  • Site Intelligence Widget
  • Protocol Feedback Loop
  • Site Performance Index
  • Pricing

Learn

  • About MyTrial
  • Founder
  • How our AI works
  • Learn center
  • Glossary

Trust

  • Transparency Center
  • Talk to a person
  • Privacy
  • Terms
  • Compliance
I'm here as
I'm a:

AI-generated content on MyTrial is labeled and clickable for full provenance — agent identity, model, prompt version, confidence, tool calls, and event chain. AB 489 disclosure is a non-negotiable audit trail, not a footer pill. Read more.

© 2026 MyTrial. Made with for patients.

Privacy · Terms · Accessibility